Soho Square, Mumbai has bagged yet another huge account this year. Following the two big wins of Vasmol and Faber in January and February, they have now been roped in to handle the brand duties for Nicotex – Cipla Health’s smoking cessation gum.
Himava Nath, Head Marketing, Cipla Health: Nicotex, the No. 1 doctor recommended brand in India, is the leading brand in smoking cessation. We have got significant growth for the brand, but we have only scratched the surface. Research shows that India is home to 12% of the world’s smokers, we feel SOHO can help us unlock the true potential of the brand and achieve our vision of a smoking free India.
Samrat Bedi, Head of Office – Soho Square, Mumbai: Cipla Health is a big brand and we are glad that they have given us this opportunity. Nicotex is the market leader in the category, and Soho has been entrusted with strengthening this position. Cipla Health chose us having noticed the value we bring to the existing brands we handle… Of course, this is a very big win.
Shashank Lanjekar, Senior VP – Strategic Planning, Soho Square, Mumbai: Nicotex is a challenging brand on two counts. Firstly, it operates in that rare category where prospects will stop buying the product forever after about 12-15 weeks if they use it correctly. Secondly, it’s an assignment of classic behaviour change albeit with a difference. Here, it’s addiction we are addressing. And that’s as difficult as it gets. So yes, we are very excited to get started.
